since tetrodotoxin is a highly specific sodium channel blocker , these data suggest that the enhanced antiarrhythmic activity of mexiletine-quinidine combination therapy involves , at least in part , blockade of the cardiac sodium channel .
C0003195
antiarrhythmic
C0034414
quinidine